Global Alprostadil Injection Market Research Report 2026(Status and Outlook)

May 2026 | 154 pages | ID: G4BCD1194CE4EN
Bosson Research

Abstracts

A prostaglandinThe global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Alprostadil Injection market size was estimated at USD 1428.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Alprostadil Injection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Alprostadil Injection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Alprostadil Injection market.

Global Alprostadil Injection Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Louston
• CP Group
• Yinglian Biopharmaceutical
• Green Biology
• HPGC
• Swiss Parenterals
• Endo Pharm
• Ferring Pharmaceuticals
• Hikma Pharmaceuticals
• Lifespan Biotech
• Viatris
• Orifarm Group
• Pfizer
• Sandoz
• Teva Pharmaceutical
• Beijing Tide Pharmaceutical

Market Segmentation (by Type)

• 0.5Mg/Ml
• 1Mg/Ml
• 2Mg/Ml
• Other

Market Segmentation (by Application)

• Myocardial Infarction
• Thrombotic Vasculitis
• Occlusive Arteriosclerosis
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Alprostadil Injection Market

Overview of the regional outlook of the Alprostadil Injection Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alprostadil Injection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Alprostadil Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Alprostadil Injection
1.2 Key Market Segments
  1.2.1 Alprostadil Injection Segment by Type
  1.2.2 Alprostadil Injection Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ALPROSTADIL INJECTION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Alprostadil Injection Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Alprostadil Injection Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ALPROSTADIL INJECTION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Alprostadil Injection Product Life Cycle
3.3 Global Alprostadil Injection Sales by Manufacturers (2020-2025)
3.4 Global Alprostadil Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Alprostadil Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Alprostadil Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Alprostadil Injection Market Competitive Situation and Trends
  3.8.1 Alprostadil Injection Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Alprostadil Injection Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ALPROSTADIL INJECTION INDUSTRY CHAIN ANALYSIS

4.1 Alprostadil Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ALPROSTADIL INJECTION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Alprostadil Injection Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Alprostadil Injection Market
5.7 ESG Ratings of Leading Companies

6 ALPROSTADIL INJECTION MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alprostadil Injection Sales Market Share by Type (2020-2025)
6.3 Global Alprostadil Injection Market Size by Type (2020-2025)
6.4 Global Alprostadil Injection Price by Type (2020-2025)

7 ALPROSTADIL INJECTION MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alprostadil Injection Market Sales by Application (2020-2025)
7.3 Global Alprostadil Injection Market Size (M USD) by Application (2020-2025)
7.4 Global Alprostadil Injection Sales Growth Rate by Application (2020-2025)

8 ALPROSTADIL INJECTION MARKET SALES BY REGION

8.1 Global Alprostadil Injection Sales by Region
  8.1.1 Global Alprostadil Injection Sales by Region
  8.1.2 Global Alprostadil Injection Sales Market Share by Region
8.2 Global Alprostadil Injection Market Size by Region
  8.2.1 Global Alprostadil Injection Market Size by Region
  8.2.2 Global Alprostadil Injection Market Size by Region
8.3 North America
  8.3.1 North America Alprostadil Injection Sales by Country
  8.3.2 North America Alprostadil Injection Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Alprostadil Injection Sales by Country
  8.4.2 Europe Alprostadil Injection Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Alprostadil Injection Sales by Region
  8.5.2 Asia Pacific Alprostadil Injection Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Alprostadil Injection Sales by Country
  8.6.2 South America Alprostadil Injection Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Alprostadil Injection Sales by Region
  8.7.2 Middle East and Africa Alprostadil Injection Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ALPROSTADIL INJECTION MARKET PRODUCTION BY REGION

9.1 Global Production of Alprostadil Injection by Region(2020-2025)
9.2 Global Alprostadil Injection Revenue Market Share by Region (2020-2025)
9.3 Global Alprostadil Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Alprostadil Injection Production
  9.4.1 North America Alprostadil Injection Production Growth Rate (2020-2025)
  9.4.2 North America Alprostadil Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Alprostadil Injection Production
  9.5.1 Europe Alprostadil Injection Production Growth Rate (2020-2025)
  9.5.2 Europe Alprostadil Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Alprostadil Injection Production (2020-2025)
  9.6.1 Japan Alprostadil Injection Production Growth Rate (2020-2025)
  9.6.2 Japan Alprostadil Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Alprostadil Injection Production (2020-2025)
  9.7.1 China Alprostadil Injection Production Growth Rate (2020-2025)
  9.7.2 China Alprostadil Injection Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Louston
  10.1.1 Louston Basic Information
  10.1.2 Louston Alprostadil Injection Product Overview
  10.1.3 Louston Alprostadil Injection Product Market Performance
  10.1.4 Louston Business Overview
  10.1.5 Louston SWOT Analysis
  10.1.6 Louston Recent Developments
10.2 CP Group
  10.2.1 CP Group Basic Information
  10.2.2 CP Group Alprostadil Injection Product Overview
  10.2.3 CP Group Alprostadil Injection Product Market Performance
  10.2.4 CP Group Business Overview
  10.2.5 CP Group SWOT Analysis
  10.2.6 CP Group Recent Developments
10.3 Yinglian Biopharmaceutical
  10.3.1 Yinglian Biopharmaceutical Basic Information
  10.3.2 Yinglian Biopharmaceutical Alprostadil Injection Product Overview
  10.3.3 Yinglian Biopharmaceutical Alprostadil Injection Product Market Performance
  10.3.4 Yinglian Biopharmaceutical Business Overview
  10.3.5 Yinglian Biopharmaceutical SWOT Analysis
  10.3.6 Yinglian Biopharmaceutical Recent Developments
10.4 Green Biology
  10.4.1 Green Biology Basic Information
  10.4.2 Green Biology Alprostadil Injection Product Overview
  10.4.3 Green Biology Alprostadil Injection Product Market Performance
  10.4.4 Green Biology Business Overview
  10.4.5 Green Biology Recent Developments
10.5 HPGC
  10.5.1 HPGC Basic Information
  10.5.2 HPGC Alprostadil Injection Product Overview
  10.5.3 HPGC Alprostadil Injection Product Market Performance
  10.5.4 HPGC Business Overview
  10.5.5 HPGC Recent Developments
10.6 Swiss Parenterals
  10.6.1 Swiss Parenterals Basic Information
  10.6.2 Swiss Parenterals Alprostadil Injection Product Overview
  10.6.3 Swiss Parenterals Alprostadil Injection Product Market Performance
  10.6.4 Swiss Parenterals Business Overview
  10.6.5 Swiss Parenterals Recent Developments
10.7 Endo Pharm
  10.7.1 Endo Pharm Basic Information
  10.7.2 Endo Pharm Alprostadil Injection Product Overview
  10.7.3 Endo Pharm Alprostadil Injection Product Market Performance
  10.7.4 Endo Pharm Business Overview
  10.7.5 Endo Pharm Recent Developments
10.8 Ferring Pharmaceuticals
  10.8.1 Ferring Pharmaceuticals Basic Information
  10.8.2 Ferring Pharmaceuticals Alprostadil Injection Product Overview
  10.8.3 Ferring Pharmaceuticals Alprostadil Injection Product Market Performance
  10.8.4 Ferring Pharmaceuticals Business Overview
  10.8.5 Ferring Pharmaceuticals Recent Developments
10.9 Hikma Pharmaceuticals
  10.9.1 Hikma Pharmaceuticals Basic Information
  10.9.2 Hikma Pharmaceuticals Alprostadil Injection Product Overview
  10.9.3 Hikma Pharmaceuticals Alprostadil Injection Product Market Performance
  10.9.4 Hikma Pharmaceuticals Business Overview
  10.9.5 Hikma Pharmaceuticals Recent Developments
10.10 Lifespan Biotech
  10.10.1 Lifespan Biotech Basic Information
  10.10.2 Lifespan Biotech Alprostadil Injection Product Overview
  10.10.3 Lifespan Biotech Alprostadil Injection Product Market Performance
  10.10.4 Lifespan Biotech Business Overview
  10.10.5 Lifespan Biotech Recent Developments
10.11 Viatris
  10.11.1 Viatris Basic Information
  10.11.2 Viatris Alprostadil Injection Product Overview
  10.11.3 Viatris Alprostadil Injection Product Market Performance
  10.11.4 Viatris Business Overview
  10.11.5 Viatris Recent Developments
10.12 Orifarm Group
  10.12.1 Orifarm Group Basic Information
  10.12.2 Orifarm Group Alprostadil Injection Product Overview
  10.12.3 Orifarm Group Alprostadil Injection Product Market Performance
  10.12.4 Orifarm Group Business Overview
  10.12.5 Orifarm Group Recent Developments
10.13 Pfizer
  10.13.1 Pfizer Basic Information
  10.13.2 Pfizer Alprostadil Injection Product Overview
  10.13.3 Pfizer Alprostadil Injection Product Market Performance
  10.13.4 Pfizer Business Overview
  10.13.5 Pfizer Recent Developments
10.14 Sandoz
  10.14.1 Sandoz Basic Information
  10.14.2 Sandoz Alprostadil Injection Product Overview
  10.14.3 Sandoz Alprostadil Injection Product Market Performance
  10.14.4 Sandoz Business Overview
  10.14.5 Sandoz Recent Developments
10.15 Teva Pharmaceutical
  10.15.1 Teva Pharmaceutical Basic Information
  10.15.2 Teva Pharmaceutical Alprostadil Injection Product Overview
  10.15.3 Teva Pharmaceutical Alprostadil Injection Product Market Performance
  10.15.4 Teva Pharmaceutical Business Overview
  10.15.5 Teva Pharmaceutical Recent Developments
10.16 Beijing Tide Pharmaceutical
  10.16.1 Beijing Tide Pharmaceutical Basic Information
  10.16.2 Beijing Tide Pharmaceutical Alprostadil Injection Product Overview
  10.16.3 Beijing Tide Pharmaceutical Alprostadil Injection Product Market Performance
  10.16.4 Beijing Tide Pharmaceutical Business Overview
  10.16.5 Beijing Tide Pharmaceutical Recent Developments

11 ALPROSTADIL INJECTION MARKET FORECAST BY REGION

11.1 Global Alprostadil Injection Market Size Forecast
11.2 Global Alprostadil Injection Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Alprostadil Injection Market Size Forecast by Country
  11.2.3 Asia Pacific Alprostadil Injection Market Size Forecast by Region
  11.2.4 South America Alprostadil Injection Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Alprostadil Injection by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Alprostadil Injection Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Alprostadil Injection by Type (2026-2035)
  12.1.2 Global Alprostadil Injection Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Alprostadil Injection by Type (2026-2035)
12.2 Global Alprostadil Injection Market Forecast by Application (2026-2035)
  12.2.1 Global Alprostadil Injection Sales (K MT) Forecast by Application
  12.2.2 Global Alprostadil Injection Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Alprostadil Injection Market Size by Type (M USD)
Table 4. Global Alprostadil Injection Market Size by Application
Table 5. Alprostadil Injection Market Size Comparison by Region (M USD)
Table 6. Global Alprostadil Injection Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Alprostadil Injection Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Alprostadil Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Alprostadil Injection Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alprostadil Injection as of 2025)
Table 11. Global Market Alprostadil Injection Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Alprostadil Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alprostadil Injection Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Alprostadil Injection Sales by Type (K MT)
Table 27. Global Alprostadil Injection Market Size by Type (M USD)
Table 28. Global Alprostadil Injection Sales (K MT) by Type (2020-2025)
Table 29. Global Alprostadil Injection Sales Market Share by Type (2020-2025)
Table 30. Global Alprostadil Injection Market Size (M USD) by Type (2020-2025)
Table 31. Global Alprostadil Injection Market Share by Type (2020-2025)
Table 32. Global Alprostadil Injection Price (USD/KG) by Type (2020-2025)
Table 33. Global Alprostadil Injection Sales (K MT) by Application
Table 34. Global Alprostadil Injection Market Size by Application
Table 35. Global Alprostadil Injection Sales by Application (2020-2025) & (K MT)
Table 36. Global Alprostadil Injection Sales Market Share by Application (2020-2025)
Table 37. Global Alprostadil Injection Market Size by Application (2020-2025) & (M USD)
Table 38. Global Alprostadil Injection Market Share by Application (2020-2025)
Table 39. Global Alprostadil Injection Sales Growth Rate by Application (2020-2025)
Table 40. Global Alprostadil Injection Sales by Region (2020-2025) & (K MT)
Table 41. Global Alprostadil Injection Sales Market Share by Region (2020-2025)
Table 42. Global Alprostadil Injection Market Size by Region (2020-2025) & (M USD)
Table 43. Global Alprostadil Injection Market Size by Region (2020-2025)
Table 44. North America Alprostadil Injection Sales by Country (2020-2025) & (K MT)
Table 45. North America Alprostadil Injection Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Alprostadil Injection Sales by Country (2020-2025) & (K MT)
Table 47. Europe Alprostadil Injection Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Alprostadil Injection Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Alprostadil Injection Market Size by Region (2020-2025) & (M USD)
Table 50. South America Alprostadil Injection Sales by Country (2020-2025) & (K MT)
Table 51. South America Alprostadil Injection Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Alprostadil Injection Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Alprostadil Injection Market Size by Region (2020-2025) & (M USD)
Table 54. Global Alprostadil Injection Production (K MT) by Region(2020-2025)
Table 55. Global Alprostadil Injection Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Alprostadil Injection Revenue Market Share by Region (2020-2025)
Table 57. Global Alprostadil Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Alprostadil Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Alprostadil Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Alprostadil Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Alprostadil Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Louston Basic Information
Table 63. Louston Alprostadil Injection Product Overview
Table 64. Louston Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Louston Business Overview
Table 66. Louston SWOT Analysis
Table 67. Louston Recent Developments
Table 68. CP Group Basic Information
Table 69. CP Group Alprostadil Injection Product Overview
Table 70. CP Group Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CP Group Business Overview
Table 72. CP Group SWOT Analysis
Table 73. CP Group Recent Developments
Table 74. Yinglian Biopharmaceutical Basic Information
Table 75. Yinglian Biopharmaceutical Alprostadil Injection Product Overview
Table 76. Yinglian Biopharmaceutical Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Yinglian Biopharmaceutical Business Overview
Table 78. Yinglian Biopharmaceutical SWOT Analysis
Table 79. Yinglian Biopharmaceutical Recent Developments
Table 80. Green Biology Basic Information
Table 81. Green Biology Alprostadil Injection Product Overview
Table 82. Green Biology Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Green Biology Business Overview
Table 84. Green Biology Recent Developments
Table 85. HPGC Basic Information
Table 86. HPGC Alprostadil Injection Product Overview
Table 87. HPGC Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. HPGC Business Overview
Table 89. HPGC Recent Developments
Table 90. Swiss Parenterals Basic Information
Table 91. Swiss Parenterals Alprostadil Injection Product Overview
Table 92. Swiss Parenterals Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Swiss Parenterals Business Overview
Table 94. Swiss Parenterals Recent Developments
Table 95. Endo Pharm Basic Information
Table 96. Endo Pharm Alprostadil Injection Product Overview
Table 97. Endo Pharm Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Endo Pharm Business Overview
Table 99. Endo Pharm Recent Developments
Table 100. Ferring Pharmaceuticals Basic Information
Table 101. Ferring Pharmaceuticals Alprostadil Injection Product Overview
Table 102. Ferring Pharmaceuticals Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ferring Pharmaceuticals Business Overview
Table 104. Ferring Pharmaceuticals Recent Developments
Table 105. Hikma Pharmaceuticals Basic Information
Table 106. Hikma Pharmaceuticals Alprostadil Injection Product Overview
Table 107. Hikma Pharmaceuticals Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Hikma Pharmaceuticals Business Overview
Table 109. Hikma Pharmaceuticals Recent Developments
Table 110. Lifespan Biotech Basic Information
Table 111. Lifespan Biotech Alprostadil Injection Product Overview
Table 112. Lifespan Biotech Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Lifespan Biotech Business Overview
Table 114. Lifespan Biotech Recent Developments
Table 115. Viatris Basic Information
Table 116. Viatris Alprostadil Injection Product Overview
Table 117. Viatris Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Viatris Business Overview
Table 119. Viatris Recent Developments
Table 120. Orifarm Group Basic Information
Table 121. Orifarm Group Alprostadil Injection Product Overview
Table 122. Orifarm Group Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Orifarm Group Business Overview
Table 124. Orifarm Group Recent Developments
Table 125. Pfizer Basic Information
Table 126. Pfizer Alprostadil Injection Product Overview
Table 127. Pfizer Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Pfizer Business Overview
Table 129. Pfizer Recent Developments
Table 130. Sandoz Basic Information
Table 131. Sandoz Alprostadil Injection Product Overview
Table 132. Sandoz Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sandoz Business Overview
Table 134. Sandoz Recent Developments
Table 135. Teva Pharmaceutical Basic Information
Table 136. Teva Pharmaceutical Alprostadil Injection Product Overview
Table 137. Teva Pharmaceutical Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Teva Pharmaceutical Business Overview
Table 139. Teva Pharmaceutical Recent Developments
Table 140. Beijing Tide Pharmaceutical Basic Information
Table 141. Beijing Tide Pharmaceutical Alprostadil Injection Product Overview
Table 142. Beijing Tide Pharmaceutical Alprostadil Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Beijing Tide Pharmaceutical Business Overview
Table 144. Beijing Tide Pharmaceutical Recent Developments
Table 145. Global Alprostadil Injection Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Alprostadil Injection Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Alprostadil Injection Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Alprostadil Injection Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Alprostadil Injection Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Alprostadil Injection Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Alprostadil Injection Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Alprostadil Injection Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Alprostadil Injection Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Alprostadil Injection Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Alprostadil Injection Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Alprostadil Injection Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Alprostadil Injection Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Alprostadil Injection Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Alprostadil Injection Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Alprostadil Injection Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Alprostadil Injection Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Alprostadil Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alprostadil Injection Market Size (M USD), 2025-2035
Figure 5. Global Alprostadil Injection Market Size (M USD) (2020-2035)
Figure 6. Global Alprostadil Injection Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alprostadil Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Alprostadil Injection Product Life Cycle
Figure 13. Alprostadil Injection Sales Share by Manufacturers in 2025
Figure 14. Global Alprostadil Injection Revenue Share by Manufacturers in 2025
Figure 15. Alprostadil Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Alprostadil Injection Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Alprostadil Injection Revenue in 2025
Figure 18. Industry Chain Map of Alprostadil Injection
Figure 19. Global Alprostadil Injection Market PEST Analysis
Figure 20. Global Alprostadil Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Alprostadil Injection Market Share by Type
Figure 27. Sales Market Share of Alprostadil Injection by Type (2020-2025)
Figure 28. Sales Market Share of Alprostadil Injection by Type in 2025
Figure 29. Market Share of Alprostadil Injection by Type (2020-2025)
Figure 30. Market Share of Alprostadil Injection by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Alprostadil Injection Market Share by Application
Figure 33. Global Alprostadil Injection Sales Market Share by Application (2020-2025)
Figure 34. Global Alprostadil Injection Sales Market Share by Application in 2025
Figure 35. Global Alprostadil Injection Market Share by Application (2020-2025)
Figure 36. Global Alprostadil Injection Market Share by Application in 2025
Figure 37. Global Alprostadil Injection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Alprostadil Injection Sales Market Share by Region (2020-2025)
Figure 39. Global Alprostadil Injection Market Size by Region (2020-2025)
Figure 40. North America Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Alprostadil Injection Sales Market Share by Country in 2024
Figure 43. North America Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Alprostadil Injection Market Size by Country in 2024
Figure 45. U.S. Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Alprostadil Injection Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Alprostadil Injection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Alprostadil Injection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Alprostadil Injection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Alprostadil Injection Sales Market Share by Country in 2024
Figure 53. Europe Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Alprostadil Injection Market Size by Country in 2024
Figure 55. Germany Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Alprostadil Injection Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Alprostadil Injection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Alprostadil Injection Market Size by Region in 2024
Figure 68. China Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Alprostadil Injection Sales and Growth Rate (K MT)
Figure 79. South America Alprostadil Injection Sales Market Share by Country in 2024
Figure 80. South America Alprostadil Injection Market Size and Growth Rate (M USD)
Figure 81. South America Alprostadil Injection Market Size by Country in 2024
Figure 82. Brazil Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Alprostadil Injection Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Alprostadil Injection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Alprostadil Injection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Alprostadil Injection Market Size by Region in 2024
Figure 92. Saudi Arabia Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Alprostadil Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Alprostadil Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Alprostadil Injection Production Market Share by Region (2020-2025)
Figure 103. North America Alprostadil Injection Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Alprostadil Injection Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Alprostadil Injection Production (K MT) Growth Rate (2020-2025)
Figure 106. China Alprostadil Injection Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Alprostadil Injection Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Alprostadil Injection Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Alprostadil Injection Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Alprostadil Injection Market Share Forecast by Type (2026-2035)
Figure 111. Global Alprostadil Injection Sales Forecast by Application (2026-2035)
Figure 112. Global Alprostadil Injection Market Share Forecast by Application (2026-2035)